Use of antibodies that specifically bind to amyloid-beta peptide for the manufacture of medicaments for treating diseases characterized by aberrant deposition of amyloid-beta, pharmaceutical compositions comprising them and methods for making them

摘要

Monoclonal antibody 9TL and antibodies derived from 9TL directed against amyloid-beta peptide and methods of using same for diagnosing and treatment of Alzheimer's disease and A²; peptide associated diseases are described. Methods of using antibodies directed against amyloid-beta peptide having impaired effector function for treatment of Alzheimer's disease and A²; peptide associated diseases are also described.